-
Mashup Score: 1Annals Consult Guys - Preoperative Risk Assessment in the Setting of Underlying Cardiac Disease | Annals of Internal Medicine - 18 day(s) ago
The Annals Consult Guys help a viewer assess risk before surgery for an octogenarian with substantial underlying comorbidity.
Source: www.acpjournals.orgCategories: General Medicine NewsTweet
-
Mashup Score: 8
For patients with immune-mediated inflammatory diseases, CVD mortality decreased from 1999 to 2020, but sex disparities persist.
Source: www.thecardiologyadvisor.comCategories: General Medicine News, Cardiology News and JournTweet-
From 1999 – 2020, there was a decrease in #CVD mortality among both women and men with IMID, but mortality rates were higher for women, according to research. Learn more in @CardioAdvisor: https://t.co/JtevqgPuAu
-
-
Mashup Score: 0
At this early age, metabolism is already dysregulated and lifestyle changes are warranted to prevent future disease.
Source: www.tctmd.comCategories: General Medicine NewsTweet-
A new study shows children as young as 10 years old who have central adiposity could face a higher #CVD risk. Read more in @TCTMD: https://t.co/7VPZrb8sq6
-
-
Mashup Score: 8CVD Polypill a High Value, Cost Savings Treatment in Underserved Population - American College of Cardiology - 5 month(s) ago
A polypill for cardiovascular disease may be cost saving and a high value treatment in a low-income, majority Black population with limited health care access at a price point of $463, according to findings from a cost-effectiveness study published Jan. 8 in JAMA Cardiology. Ciaran Kohli-Lynch, PhD, et al., used a computer simulation model to assess the cost-effectiveness of a cardiovascular polypill compared with u sual care over 10 years. The primary cohort consisted of a trial representative cohort of
Source: www.acc.orgCategories: General Medicine News, CardiologistsTweet-
A polypill for cardiovascular disease may be cost saving & a high value treatment in a low-income, majority Black population w/ limited health care access at a price point of $463, according to findings from a cost-effectiveness study. Read more: https://t.co/bHzh0wFpPJ #CVD
-
-
Mashup Score: 9The Association of Plasma and Urine Uromodulin With Cardiovascular Disease in Persons With Hypertension and CKD - 7 month(s) ago
Uromodulin (UMOD) is a protein synthesized exclusively by tubular epithelial cells in the kidney. Higher urinary UMOD levels appear to reflect kidney tubule functional mass based on their direct association with kidney size, indices of tubular function, and lower risk of kidney disease progression.1 Higher UMOD concentrations in both the blood and urine have each been associated with lower rates of cardiovascular disease (CVD), but largely in separate cohorts.2,3 Owing to degradation and aggregation during storage,4 as well as changes in concentration from hydration,5 there are practical challenges to using urine UMOD measurements.
Source: www.ajkd.orgCategories: General Medicine News, NephrologyTweet-
The Association of Plasma and Urine Uromodulin With Cardiovascular Disease in Persons With Hypertension and CKD https://t.co/9fN56pmHrS (FREE) @j_ikeme @pranavgarimella @estrella_khrc @shlipak_khrc @UCSFNephrology @KHRC_research #CVD https://t.co/736izBsJqO
-
-
Mashup Score: 2A Framework for Considering the Value of Race and Ethnicity in Estimating Disease Risk | Annals of Internal Medicine - 7 month(s) ago
Background: Accounting for race and ethnicity in estimating disease risk may improve the accuracy of predictions but may also encourage a racialized view of medicine. Objective: To present a decision analytic framework for considering the potential benefits of race-aware over race-unaware risk predictions, using cardiovascular disease, breast cancer, and lung cancer as case studies. Design: Cross-sectional study. Setting: NHANES (National Health and Nutrition Examination Survey), 2011 to 2018, and NLST (National Lung Screening Trial), 2002 to 2004. Patients: U.S. adults. Measurements: Starting with risk predictions from clinically recommended race-aware models, the researchers generated race-unaware predictions via statistical marginalization. They then estimated the utility gains of the race-aware over the race-unaware models, based on a simple utility function that assumes constant costs of screening and constant benefits of disease detection. Results: The race-unaware predictions we
Source: www.acpjournals.orgCategories: General Medicine News, General Journals & SocietTweet-
A new @AnnalsofIM paper presents a decision analytic framework for considering the potential benefits of race-aware over race-unaware risk predictions, using #CVD, breast cancer, and lung cancer as case studies. https://t.co/bpgM4P8CBH https://t.co/9uAApAaRUl
-
-
Mashup Score: 24The Association of Plasma and Urine Uromodulin With Cardiovascular Disease in Persons With Hypertension and CKD - 9 month(s) ago
Uromodulin (UMOD) is a protein synthesized exclusively by tubular epithelial cells in the kidney. Higher urinary UMOD levels appear to reflect kidney tubule functional mass based on their direct association with kidney size, indices of tubular function, and lower risk of kidney disease progression.1 Higher UMOD concentrations in both the blood and urine have each been associated with lower rates of cardiovascular disease (CVD), but largely in separate cohorts.2,3 Owing to degradation and aggregation during storage,4 as well as changes in concentration from hydration,5 there are practical challenges to using urine UMOD measurements.
Source: www.ajkd.orgCategories: General Medicine News, NephrologyTweet-
The Association of Plasma and Urine Uromodulin With Cardiovascular Disease in Persons With Hypertension and CKD https://t.co/jFsFQMRY6s (FREE) @j_ikeme @pranavgarimella @estrella_khrc @shlipak_khrc @UCSFNephrology @KHRC_research #CVD https://t.co/CK9gdca9UY
-
-
Mashup Score: 0ESC President, Prof Weidinger: “We need a common cardiac health plan to combat this burden” - 1 year(s) ago
Your access to the latest cardiovascular news, science, tools and resources.
Source: www.escardio.orgCategories: General Medicine News, CardiologistsTweet-
Professor Weidinger's successful two-year tenure as @ESC_President will conclude in September. Under the leadership of the Austrian cardiologist, the ESC has made notable strides in putting cardiovascular disease on the European political agenda. https://t.co/v9GMS2WO5s #CVD https://t.co/Fa3rmiCQqu
-
-
Mashup Score: 55
Background: There is little consensus on using statins for primary prevention of cardiovascular diseases (CVDs) and all-cause mortality in adults aged 75 years or older due to the underrepresentation of this population in randomized controlled trials. Objective: To investigate the benefits and risks of using statins for primary prevention in old (aged 75 to 84 years) and very old (aged ≥85 years) adults. Design: Sequential target trial emulation comparing matched cohorts initiating versus not initiating statin therapy. Setting: Territory-wide public electronic medical records in Hong Kong. Participants: Persons aged 75 years or older who met indications for statin initiation from January 2008 to December 2015 were included. Participants with preexisting diagnosed CVDs at baseline, such as coronary heart disease (CHD), were excluded from the analysis. Among 69 981 eligible persons aged 75 to 84 years and 14 555 persons aged 85 years or older, 41 884 and 9457 had history of CHD equivalen
Source: www.acpjournals.orgCategories: General Medicine News, CardiologistsTweet-
Important new study in @AnnalsofIM showing safety & significant benefit of statins for primary #CVD prevention of stroke, MI & mortality in adults over 75 yo, even 85 yo+: https://t.co/CgeDl4JOPY https://t.co/wdTYcyjiEt
-
-
Mashup Score: 0
Death rate vs urban areas continues to widen for cancer, heart disease, lung disease, and stroke
Source: www.medpagetoday.comCategories: General Medicine News, Cardiology News and JournTweet-
Rural Americans have higher rates 📈 of preventable premature mortality from the 5️⃣ leading causes of death than those living in urban areas, according to the CDC. More from @medpagetoday: https://t.co/UCid9tFfOV #CVD
-
Watch the Annals @ConsultGuys Drs. Geno Merli @GenoMerli and Howard Weitz @DrHowardWeitz discuss preoperative risk assessments for an octogenarian with underlying cardiac disease. #CVD https://t.co/hsMZKAkI3N https://t.co/ZRxpYFuZVn